1 / 12

Clinical islet transplantation

Diabetes Research Group. Clinical islet transplantation. Stephanie A Amiel, BSc, MD, FRCP RD Lawrence Professor of Diabetic Medicine King’s College London School of Medicine. INSU U100. Treatment of organ failure?. Renal failure Liver failure Heart failure Islet failure.

karis
Download Presentation

Clinical islet transplantation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Diabetes Research Group Clinical islet transplantation Stephanie A Amiel, BSc, MD, FRCP RD Lawrence Professor of Diabetic Medicine King’s College London School of Medicine

  2. INSU U100 Treatment of organ failure? • Renal failure • Liver failure • Heart failure • Islet failure • Kidney transplant • Liver transplant • Heart transplant

  3. Case Histories • Born 1944; T1DM 1966; keen runner • Born 1965; T1DM 1987; HCA on locked ward • Born 1985; T1DM 1994; mother of two “afraid to be in charge of my granddaughter” “threatened with medical redundancy” “you just drove across a red light, Mummy”

  4. GLUCOSE-RESPONSIVEINSULIN DELIVERY Bionics vs nature?

  5. Nature – whole pancreas or islets?

  6. Islet Transplantation • 1998 established laboratory • 2000 proof of concept • 2002 1st UK patient • 2008 NCG funded programme

  7. CITR Islet Alone Recipients outcome From all infusions Insulin Independence, Insulin Dependence, Graft failure *C-peptide data not available at Day 75 **Year 3 status independent of re-infusion

  8. SEVERE HYPOGLYCEMIA FOLLOWING LAST TRANSPLANT CITR 2007

  9. Clinical Outcomes: Diabetes UK patients • 3 people achieved insulin independence • 1 person with 4% reduction in HbA1c • 2 people back in work • 1 woman resumed running and babysitting her grandchildren • 2 children safely back on school run

  10. UK ITC NCG: April 2008 2 isolation centres 6 Transplant centres Intractable hypoglycaemia Islet after kidney Local and remote Shaw, Manus, Amiel, Huang

  11. Problems to be solved • Current • Organ supply/distribution • Sub-optimal immunosuppression • Research • Prevent loss of islets on administration • Improve immunosuppression • Make new islets to give greater loads and re-transplant if required

  12. Meanwhile • Whatever cell therapy we devise, it will need to be safer than insulin therapy • For a small number of patients, it already is

More Related